Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03074292
Other study ID # 00006444
Secondary ID
Status Active, not recruiting
Phase N/A
First received February 16, 2017
Last updated March 7, 2017
Start date December 2013
Est. completion date March 2017

Study information

Verified date March 2017
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present study is to test a hypothesis assuming that phototherapy might have an effect on oxidant/antioxidant status in term and late-preterm neonates with unconjugated hyperbilirubinemia.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 120
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group N/A to 28 Days
Eligibility Inclusion Criteria:

- Term and late-preterm neonates (=35weeks) according to the guidelines of the American Academy of Pediatrics (2004) which stated that gestational ages of newborns were determined according to the first day of the mother's last menstrual period (by the mother's statement) and were additionally confirmed by the Ballard scoring system (Ballard et al., 1991) and antenatal ultrasonographic estimation or obstetric records if present.

- Clinical significant indirect hyperbilirubinemia requiring phototherapy in the first week of life.

- Normal blood counts and peripheral blood smears

- Normal reticulocytic count.

- Breast fed newborn.

Exclusion Criteria:

- Those in whom the total serum bilirubin (TSB) level rose by more than 5 mg/dl per day or was higher than 20 mg/dl within the first 24 hours after birth were excluded from the study.

- Infant of diabetic mothers.

- Maternal eclampsia-preeclampsia.

- Birth asphyxia

- Sepsis

- congenital anomalies.

- Direct Coombs`test positive

- Pathological causes of hyperbilirubinemia.

- Enclosed hemorrhage.

- Hemolytic type of hyperbilirubinemia due to blood group or Rh incompatibility.

Study Design


Intervention

Procedure:
phototherapy
estimate oxidative stress and trace elements in neonates with unconjugated hyperbilirubinemia after exposure to phototherapy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Rania Ali El-Farrash

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of types of phototherapy on change in total antioxidant capacity (TAC) This will be determined by:
Measure TAC (mmol/L) before and after phototherapy
Compare results of TAC (mmol/L) before and after phototherapy.
2 days
Primary Effect of types of phototherapy on change in malonaldehyde (MDA) This will be determined by:
Measure MDA (nmol/L) before and after phototherapy
Compare results of MDA (nmol/L) before and after phototherapy.
2 days
Primary Effect of types of phototherapy on change in nitric oxide (NO) This will be determined by:
Measure NO (umol/L) before and after phototherapy
Compare results of NO (umol/L) before and after phototherapy.
2 days
Secondary Effect of types of phototherapy on change in serum iron (Fe) This will be determined by:
Measure serum Fe before and after phototherapy
Compare results of serum Fe before and after phototherapy.
2 days
Secondary Effect of types of phototherapy on change in serum copper (Cu) This will be determined by:
Measure serum Cu before and after phototherapy
Compare results of serum Cu before and after phototherapy.
2 days
Secondary Effect of types of phototherapy on change in serum zinc (Zn) This will be determined by:
Measure serum Zn before and after phototherapy
Compare results of serum Zn before and after phototherapy.
2 days
Secondary Effect of types of phototherapy on change in serum calcium (Zn) This will be determined by:
Measure serum Ca before and after phototherapy
Compare results of serum Ca before and after phototherapy.
2 days
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04136821 - The Long-term Effects of Oceanix™ on Resistance Training Adaptations N/A
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Completed NCT03358524 - Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia Phase 4
Recruiting NCT05327348 - Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery Phase 3
Completed NCT03288623 - The Effects of Dark Chocolate Implementation in Elite Athletes N/A
Completed NCT04419025 - Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease Phase 2
Completed NCT04597983 - Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A
Enrolling by invitation NCT03030456 - Whole Body Vibrations on Functional Capacity, Muscular Strength, and Biochemical Profile in Elders N/A
Completed NCT02256254 - SIMOX - Induction of Oxidative Stress Phase 2
Not yet recruiting NCT02202239 - Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients Phase 4
Recruiting NCT02048592 - Impact of Immunonutrition on the Patients With Cystic Fibrosis Phase 4
Completed NCT01942460 - Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients Phase 4
Completed NCT02463318 - The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects N/A
Completed NCT02177383 - Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance N/A
Completed NCT01990391 - Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities N/A
Completed NCT00845130 - Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes N/A
Completed NCT00607893 - Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea N/A
Active, not recruiting NCT00247507 - The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients Phase 4